789 Immune checkpoint blockade augments cyclophosphamide induced anti-tumor immunity by expanding effector CD8+ T cell clones in a preclinical melanoma model

Bibliographic Details
Main Authors: Alan N Houghton, Jedd D Wolchok, Taha Merghoub, Daniel Hirschhorn, Linda Hamadene, Yacine Marouf, Allison B Warner, Mariam M George, Nicholas J Ceglia
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
_version_ 1797630749993598976
author Alan N Houghton
Jedd D Wolchok
Taha Merghoub
Daniel Hirschhorn
Linda Hamadene
Yacine Marouf
Allison B Warner
Mariam M George
Nicholas J Ceglia
author_facet Alan N Houghton
Jedd D Wolchok
Taha Merghoub
Daniel Hirschhorn
Linda Hamadene
Yacine Marouf
Allison B Warner
Mariam M George
Nicholas J Ceglia
author_sort Alan N Houghton
collection DOAJ
first_indexed 2024-03-11T11:11:43Z
format Article
id doaj.art-856c991276d94616af2a5da1209a1193
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-03-11T11:11:43Z
publishDate 2023-11-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-856c991276d94616af2a5da1209a11932023-11-11T21:20:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0789789 Immune checkpoint blockade augments cyclophosphamide induced anti-tumor immunity by expanding effector CD8+ T cell clones in a preclinical melanoma modelAlan N Houghton0Jedd D Wolchok1Taha Merghoub2Daniel Hirschhorn3Linda Hamadene4Yacine Marouf5Allison B Warner6Mariam M George7Nicholas J Ceglia8Aff4 grid.51462.340000000121719952Department of MedicineMemorial Sloan Kettering Cancer Center 10065 New York NY USA1Weill Cornell Medicine, New York, NY, USA1Weill Cornell Medicine, New York, NY, USA1Weill Cornell Medicine, New York, NY, USA1Memorial Sloan-Kettering Cancer Center, New York, NY, USA1Weill Cornell Medicine, New York, NY, USA4Memorial Sloan Kettering Cancer Center, New York, NY, USA1Weill Cornell Medicine, New York, NY, USA2Memorial Sloan Kettering Cancer Center, New York, NY, USA
spellingShingle Alan N Houghton
Jedd D Wolchok
Taha Merghoub
Daniel Hirschhorn
Linda Hamadene
Yacine Marouf
Allison B Warner
Mariam M George
Nicholas J Ceglia
789 Immune checkpoint blockade augments cyclophosphamide induced anti-tumor immunity by expanding effector CD8+ T cell clones in a preclinical melanoma model
Journal for ImmunoTherapy of Cancer
title 789 Immune checkpoint blockade augments cyclophosphamide induced anti-tumor immunity by expanding effector CD8+ T cell clones in a preclinical melanoma model
title_full 789 Immune checkpoint blockade augments cyclophosphamide induced anti-tumor immunity by expanding effector CD8+ T cell clones in a preclinical melanoma model
title_fullStr 789 Immune checkpoint blockade augments cyclophosphamide induced anti-tumor immunity by expanding effector CD8+ T cell clones in a preclinical melanoma model
title_full_unstemmed 789 Immune checkpoint blockade augments cyclophosphamide induced anti-tumor immunity by expanding effector CD8+ T cell clones in a preclinical melanoma model
title_short 789 Immune checkpoint blockade augments cyclophosphamide induced anti-tumor immunity by expanding effector CD8+ T cell clones in a preclinical melanoma model
title_sort 789 immune checkpoint blockade augments cyclophosphamide induced anti tumor immunity by expanding effector cd8 t cell clones in a preclinical melanoma model
work_keys_str_mv AT alannhoughton 789immunecheckpointblockadeaugmentscyclophosphamideinducedantitumorimmunitybyexpandingeffectorcd8tcellclonesinapreclinicalmelanomamodel
AT jedddwolchok 789immunecheckpointblockadeaugmentscyclophosphamideinducedantitumorimmunitybyexpandingeffectorcd8tcellclonesinapreclinicalmelanomamodel
AT tahamerghoub 789immunecheckpointblockadeaugmentscyclophosphamideinducedantitumorimmunitybyexpandingeffectorcd8tcellclonesinapreclinicalmelanomamodel
AT danielhirschhorn 789immunecheckpointblockadeaugmentscyclophosphamideinducedantitumorimmunitybyexpandingeffectorcd8tcellclonesinapreclinicalmelanomamodel
AT lindahamadene 789immunecheckpointblockadeaugmentscyclophosphamideinducedantitumorimmunitybyexpandingeffectorcd8tcellclonesinapreclinicalmelanomamodel
AT yacinemarouf 789immunecheckpointblockadeaugmentscyclophosphamideinducedantitumorimmunitybyexpandingeffectorcd8tcellclonesinapreclinicalmelanomamodel
AT allisonbwarner 789immunecheckpointblockadeaugmentscyclophosphamideinducedantitumorimmunitybyexpandingeffectorcd8tcellclonesinapreclinicalmelanomamodel
AT mariammgeorge 789immunecheckpointblockadeaugmentscyclophosphamideinducedantitumorimmunitybyexpandingeffectorcd8tcellclonesinapreclinicalmelanomamodel
AT nicholasjceglia 789immunecheckpointblockadeaugmentscyclophosphamideinducedantitumorimmunitybyexpandingeffectorcd8tcellclonesinapreclinicalmelanomamodel